200 related articles for article (PubMed ID: 34557189)
1. HLA-G 3'UTR Polymorphisms Are Linked to Susceptibility and Survival in Spanish Gastric Adenocarcinoma Patients.
Vaquero-Yuste C; Juarez I; Molina-Alejandre M; Molanes-López EM; López-Nares A; Suárez-Trujillo F; Gutiérrez-Calvo A; López-García A; Lasa I; Gómez R; Fernández-Cruz E; Rodrígez-Sainz C; Arnaiz-Villena A; Martín-Villa JM
Front Immunol; 2021; 12():698438. PubMed ID: 34557189
[TBL] [Abstract][Full Text] [Related]
2. Association of HLA-G 3'UTR polymorphisms and haplotypes with colorectal cancer susceptibility and prognosis.
Dhouioui S; Laaribi AB; Boujelbene N; Jelassi R; Ben Salah H; Bellali H; Ouzari HI; Mezlini A; Zemni I; Chelbi H; Zidi I
Hum Immunol; 2022 Jan; 83(1):39-46. PubMed ID: 34763955
[TBL] [Abstract][Full Text] [Related]
3. Association of HLA-G 3' Untranslated Region Polymorphisms with Systemic Lupus Erythematosus in a Japanese Population: A Case-Control Association Study.
Hachiya Y; Kawasaki A; Oka S; Kondo Y; Ito S; Matsumoto I; Kusaoi M; Amano H; Suda A; Setoguchi K; Nagai T; Shimada K; Sugii S; Okamoto A; Chiba N; Suematsu E; Ohno S; Katayama M; Kono H; Hirohata S; Takasaki Y; Hashimoto H; Sumida T; Nagaoka S; Tohma S; Furukawa H; Tsuchiya N
PLoS One; 2016; 11(6):e0158065. PubMed ID: 27331404
[TBL] [Abstract][Full Text] [Related]
4. The association between functional HLA-G 14bp insertion/deletion and +3142 C>G polymorphisms and susceptibility to multiple sclerosis.
Ben Fredj N; Sakly K; Bortolotti D; Aissi M; Frih-Ayed M; Rotola A; Caselli E; Cura F; Sakly N; Aouni M; Di Luca D; Rizzo R
Immunol Lett; 2016 Dec; 180():24-30. PubMed ID: 27771469
[TBL] [Abstract][Full Text] [Related]
5. Promising link of HLA-G polymorphism, tobacco consumption and risk of Head and Neck Squamous Cell Carcinoma (HNSCC) in North Indian population.
Agnihotri V; Gupta A; Kumar R; Upadhyay AD; Dwivedi S; Kumar L; Dey S
Hum Immunol; 2017 Feb; 78(2):172-178. PubMed ID: 28040535
[TBL] [Abstract][Full Text] [Related]
6. Association of HLA-G 3'UTR polymorphisms and haplotypes with severe sepsis in a Brazilian population.
Hahn EC; Zambra FMB; Kamada AJ; Delongui F; Grion CMC; Reiche EMV; Chies JAB
Hum Immunol; 2017 Nov; 78(11-12):718-723. PubMed ID: 28941746
[TBL] [Abstract][Full Text] [Related]
7. Polymorphic sites at the 3' untranslated region of the HLA-G gene are associated with differential hla-g soluble levels in the Brazilian and French population.
Martelli-Palomino G; Pancotto JA; Muniz YC; Mendes-Junior CT; Castelli EC; Massaro JD; Krawice-Radanne I; Poras I; Rebmann V; Carosella ED; Rouas-Freiss N; Moreau P; Donadi EA
PLoS One; 2013; 8(10):e71742. PubMed ID: 24204558
[TBL] [Abstract][Full Text] [Related]
8. Association of
Kadiam S; Ramasamy T; Ramakrishnan R; Mariakuttikan J
J Clin Pathol; 2020 Aug; 73(8):456-462. PubMed ID: 31796638
[TBL] [Abstract][Full Text] [Related]
9. Genetic polymorphism in HLA-G 3'UTR 14-bp ins/del and risk of cancer: a meta-analysis of case-control study.
Li T; Huang H; Liao D; Ling H; Su B; Cai M
Mol Genet Genomics; 2015 Aug; 290(4):1235-45. PubMed ID: 25573780
[TBL] [Abstract][Full Text] [Related]
10. The Impact of
Ouni N; Chaaben AB; Kablouti G; Ayari F; Douik H; Abaza H; Gara S; Elgaaied-Benammar A; Guemira F; Tamouza R
Immunol Invest; 2019 Jul; 48(5):521-532. PubMed ID: 30945586
[TBL] [Abstract][Full Text] [Related]
11. Immunogenetics of prostate cancer and benign hyperplasia--the potential use of an HLA-G variant as a tag SNP for prostate cancer risk.
Zambra FM; Biolchi V; de Cerqueira CC; Brum IS; Castelli EC; Chies JA
HLA; 2016 Feb; 87(2):79-88. PubMed ID: 26889902
[TBL] [Abstract][Full Text] [Related]
12. HLA-G 3'UTR Polymorphisms Impact the Prognosis of Stage II-III CRC Patients in Fluoropyrimidine-Based Treatment.
Garziera M; Bidoli E; Cecchin E; Mini E; Nobili S; Lonardi S; Buonadonna A; Errante D; Pella N; D'Andrea M; De Marchi F; De Paoli A; Zanusso C; De Mattia E; Tassi R; Toffoli G
PLoS One; 2015; 10(12):e0144000. PubMed ID: 26633805
[TBL] [Abstract][Full Text] [Related]
13. Genetic variation in the
Jiang Y; Lu J; Wu YE; Zhao X; Li L
Biosci Rep; 2019 May; 39(5):. PubMed ID: 30962267
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of HLA-G 14bp Ins/Del and +3142 C/G Polymorphisms in Type 1 Diabetes among South Indian Population.
Gunavathy N; Asirvatham A; Chitra A; Jayalakshmi M
Indian J Endocrinol Metab; 2023; 27(3):223-229. PubMed ID: 37583409
[TBL] [Abstract][Full Text] [Related]
15. Association between HLA-G 3'UTR 14-bp ins/del polymorphism and susceptibility to breast cancer.
Eskandari-Nasab E; Hashemi M; Hasani SS; Omrani M; Taheri M; Mashhadi MA
Cancer Biomark; 2013; 13(4):253-9. PubMed ID: 24240586
[TBL] [Abstract][Full Text] [Related]
16. Meta-analysis of the relationship between 14bp insertion/deletion polymorphism of HLA-G gene and susceptibility to systemic lupus erythematosus.
Zhang X; Li S; Zhang Y; Lu Y; Wang J; Xu J; Li X; Qin X
Hum Immunol; 2014 Dec; 75(12):1171-6. PubMed ID: 25454623
[TBL] [Abstract][Full Text] [Related]
17. Association of
Gautam S; Kumar U; Kumar M; Kanga U; Dada R
Immunol Invest; 2020 Feb; 49(1-2):88-105. PubMed ID: 31549885
[No Abstract] [Full Text] [Related]
18. HLA-G 14bp Ins/Del Polymorphism in the 3'UTR Region and Acute Rejection in Kidney Transplant Recipients: An Updated Meta-Analysis.
Kang SW; Oh E; Cho W; Kim M; Park EJ; Kwack KH; Chung K; Nam OH; Chae YK; Ban JY
Medicina (Kaunas); 2021 Sep; 57(10):. PubMed ID: 34684043
[No Abstract] [Full Text] [Related]
19. 3'UTR-HLA-G polymorphisms and circulating sHLA-G are associated with breast cancer: Evidence from a meta-analysis.
Tizaoui K; Jalouli M; Ouzari HI; Harrath AH; Rizzo R; Boujelbene N; Zidi I
Immunol Lett; 2022 Aug; 248():78-89. PubMed ID: 35752280
[TBL] [Abstract][Full Text] [Related]
20. Association of the 3' untranslated region polymorphisms of HLA-G with susceptibility to chronic hepatitis C virus infection in the Chinese population.
Zhou S; Liu M; Xia Y; Zhang L; Shao L; Wang N; Yu W; Ding N; Zhang K; Liang X
Hum Immunol; 2022 Jan; 83(1):47-52. PubMed ID: 34556350
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
